Inventor
Warren Wade
Inventor
San Diego, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds10%
C07BGeneral methods of organic chemistry4%
Y02ATechnologies for adaptation to climate change4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
C40BCombinatorial chemistry1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
G06FElectric digital data processing1%
PatentTitleYear
10,941,159Gonadotropin-releasing hormone receptor antagonists and methods relating thereto202110,357,475IRE-1a inhibitors201910,336,769Gonadotropin-releasing hormone receptor antagonists and methods relating thereto201910,100,0453-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulators201810,087,185Fused bicylic pyridine compounds and their use as AMPA receptor modulators20189,946,847Libraries of compounds having desired properties and methods for making and using them20189,867,803'IRE-1α inhibitors'20189,856,266'IRE-1alpha inhibitors'20189,725,426'Cystathionine-γ-lyase (CSE) inhibitors'20179,693,992'IRE-1α inhibitors'20179,493,435'IRE-1α inhibitors'20169,422,310'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20169,040,714'IRE-1α inhibitors'20158,952,161'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20158,912,203'6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders'20148,680,099'6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders'20148,674,095'Compounds for treating neuropsychiatric conditions'20148,507,536'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20138,481,738'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20138,372,970'8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders'20138,263,588'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20128,084,614'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20117,419,983'Gonadotropin-releasing hormone receptor antagonists and methods related thereto'20087,378,552'Monoamine re-uptake inhibitors and methods relating thereto'20087,229,995'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20077,176,211'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20077,067,509'Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto'20067,056,927'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20067,015,226'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2021Patents assigned to NEUROCRINE BIOSCIENCES INC (15)· patent assignee history
2006–2021Based in San Diego, CA, US· patent location history
2011–2014Patents assigned to WADE WARREN (8)· patent assignee history
2011–2013Patents assigned to ASHWEEK NEIL (4)· patent assignee history
2011–2013Patents assigned to BEATON GRAHAM (4)· patent assignee history
2013–2014Patents assigned to CAMPBELL DAVID (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | 2006–2021 |
| WADE WARRENself | 8 | 2011–2014 |
| ASHWEEK NEIL | 4 | 2011–2013 |
| BEATON GRAHAM | 4 | 2011–2013 |
| CAMPBELL DAVID | 4 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 29 | 2006–2021 |